Team | Board of Directors

Prof. Dr. Michael N. Hall

Chairman and Non-Executive Board Member

Prof. Dr. Michael N. Hall is an American and Swiss molecular biologist and Professor at the Biozentrum of the University of Basel. He earned a Ph.D. in Molecular Genetics from Harvard University in 1981 and was a postdoctoral fellow at the Institut Pasteur in Paris and the University of California, San Francisco.

Dr. Vladimir Cmiljanovic

Vice-Chairman and Executive Board Member

Dr. Vladimir Cmiljanovic is a renowned serial biotech entrepreneur, cancer scientist, and medicinal chemist with over 15 years of experience in oncology drug development.

Dr. Natasa Cmiljanovic

Executive Board Member

Dr. Natasa Cmiljanovic is a dynamic and accomplished professional, serving as the Chief Operating Officer and Founder of Swiss Rockets. With over a decade of invaluable experience in oncology drug development, Natasa's background as a medicinal chemist and clinical scientist makes her a driving force in the field.

Christoph Brutschin

Non-Executive Board Member

Christoph Brutschin obtained his economic degrees at the University of applied sciences of Zürich and at the University of Fribourg. He held positions with PWC and maxit AG (Switzerland) before becoming a headmaster of the Basel commercial vocational training college.

Dr. Thomas Ladner

Non-Executive Board Member Member & Secretary

Dr. Thomas Ladner, Board Member and Secretary of the Board, became in 2002 the youngest partner at Meyerlustenberger Lachenal, one of Switzerland's leading law firms, where he specialized in private equity and M&A. From 2000 to 2004, Thomas lectured on corporate law and contract law at the University of St. Gallen (Switzerland), from where he also holds a Ph.D.

Dr. Jeanette Wood

Non-Executive Board Member

Dr. Jeanette Wood is an accomplished scientist with extensive experience in all aspects of drug discovery across multiple disease areas, including cancer.

Christoph Tschumi

Non-Executive Board Member

Christoph Tschumi is a senior business consultant with a focus on organisational development, governance, as well as economic analysis and risk management. He is member of various boards. In the Foundation Board of the Basel Institute on Governance, as well as the board of Pension Fund of the Canton Basel-Stadt he is head of the finance and audit committees.